Clinical Innovations is the leading, global pure-play provider of single-use clinician-preferred medical devices for hospitals’ Labor & Delivery (L&D) and Neonatal Intensive Care Unit (NICU) departments.
Founded in 1993, Clinical Innovations is the largest independent medical device company exclusively focused on L&D. Already a market leader in several categories with products such as the Kiwi® Vacuum-Assisted Delivery System and Koala® Intrauterine Pressure Catheter, Clinical Innovations is developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and babies around the world. The Company has a well-balanced L&D and NICU portfolio of best-in-class, market-leading, established products as well as high-growth new products.
Clinical Innovations has built the industry’s largest specialized L&D-focused sales force and has developed strong relationships with specialty medical device distributors around the world. The company is headquartered in Utah and their products are sold in more than 2,300 hospitals in the US and more than 80 countries globally.
Market trends and drivers
Clinical Innovations operates in an attractive niche within medical technology that is supported by stable birth rates, high clinician influence in product choice and positive reimbursement dynamics. Market growth is driven by an increased prevalence of high-risk pregnancies and global initiatives to improve health outcomes for mothers and babies, specifically through reducing C-section rates.
EQT’s value creation plan for Clinical Innovations is focused on continuing to drive sales growth across its established and new products, accelerating international expansion into developing markets and the broadening of its of best-in-class product portfolio through acquisitions.